TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Takara Bio Europe AB
Closing information (x1000 EUR)
| Closing information | 2020/12 | 2019/12 | 2018/12 |
| Turnover |
3,037
|
3,874
|
3,936 |
| Financial expenses |
109
|
86
|
162 |
| Earnings before taxes |
-596
|
-843
|
-1,109 |
| EBITDA |
-441
|
-727
|
-880 |
| Total assets |
4,480
|
3,219
|
4,017 |
| Current assets |
2,215
|
2,063
|
2,781 |
| Current liabilities |
769
|
598
|
950 |
| Equity capital |
2,749
|
1,703
|
936 |
| - share capital |
221
|
213
|
216 |
| Employees (average) |
28
|
26
|
27 |
Financial ratios
| Fiscal year | 2020/12 | 2019/12 | 2018/12 |
| Solvency |
61.4%
|
52.9%
|
23.3% |
| Turnover per employee |
108
|
149
|
146 |
| Profit as a percentage of turnover |
-19.6%
|
-21.8%
|
-28.2% |
| Return on assets (ROA) |
-10.9%
|
-23.5%
|
-23.6% |
| Current ratio |
288.0%
|
345.0%
|
292.7% |
| Return on equity (ROE) |
-21.7%
|
-49.5%
|
-118.5% |
| Change turnover |
-990
|
-2
|
100 |
| Change turnover % |
-25%
|
0%
|
3% |
| Chg. No. of employees |
2
|
-1
|
-4 |
| Chg. No. of employees % |
8%
|
-4%
|
-13% |
Total value of public sale
| Fiscal year | 2020/12 | 2019/12 | 2018/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.